ItalyNetherlandsSpainA novel platform for the direct profiling of circulating cell-free ribonucleic acids in biofluids

July 19, 2022by pcdata0

Dates: 01/01/2021
31/12/2024


Topic: Tool


Project type: Preclinic
Theranostic


Project target: Prostate Cancer


Financing:

H2020-EU.1.3. – EXCELLENT SCIENCE – Marie Sk?odowska-Curie Actions
H2020-EU.1.3.3. – Stimulating innovation by means of cross-fertilisation of knowledge


Participating agents:

DESTINA GENOMICA SLNE
OPTOELETTRONICA ITALIA SRL
UNIVERSITA DEGLI STUDI DI CATANIA
UNIVERSITA DEGLI STUDI DI TRENTO
PRINSES MAXIMA CENTRUM VOOR KINDERONCOLOGIE BV
UNIVERSIDAD DE GRANADA


Keywords: prostate cancer; nanotechnology; RNA; liquid biopsy; Circulating cell-free ribonucleic acids; ODG Platform; testicular germ cell tumour


Countries: Spain; Italy; Netherlands


Project page: Access page

 

Leave a Reply

Your email address will not be published. Required fields are marked *